Related Experiment Video
Updated: Jun 12, 2026
07:24
Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
Characterization of mitochondrial DNA heteroplasmy using a parallel sequencing system
1Division of Human Genetics/Department of Pediatrics, University of California, Irvine, CA 92697, USA.
Biotechniques
|June 24, 2010
Summary
Next-generation sequencing accurately detects mitochondrial DNA (mtDNA) heteroplasmies at levels as low as 5%. This high-throughput method offers a sensitive and specific approach for diagnosing mitochondrial diseases.
Area of Science:
- Genomics
- Molecular Biology
- Medical Diagnostics
Background:
- Accurate characterization of human mitochondrial genome sequences is crucial for diagnosing mitochondrial diseases.
- Detecting low-level mitochondrial DNA (mtDNA) heteroplasmy (≥5%) remains a challenge for current methodologies.
- Existing methods struggle to simultaneously sequence complete mtDNA, identify genome-wide heteroplasmies, and quantify heteroplasmy levels.
Purpose of the Study:
- To evaluate the efficacy of next-generation sequencing (NGS) for detecting and quantifying mtDNA heteroplasmies.
- To assess the sensitivity, specificity, and accuracy of the Illumina Genome Analyzer for mtDNA heteroplasmy analysis.
- To establish a high-throughput, cost-effective platform for comprehensive mitochondrial genome sequencing.
Main Methods:
- Human mtDNA samples from two subjects were mixed at various ratios (1:99 to 50:50).
- Mitochondrial DNA samples were re-sequenced using the Illumina Genome Analyzer.
- The system's sensitivity, specificity, and accuracy for detecting mtDNA heteroplasmies were rigorously assessed.
Main Results:
- NGS successfully detected mtDNA heteroplasmies ≥5% with 100% sensitivity and minimal false positives.
- Quantification of mtDNA heteroplasmy levels showed high accuracy, with estimates closely matching theoretical values (correlation coefficient = 0.96).
- Deep sampling via NGS enabled efficient detection of low-level DNA heteroplasmies.
Conclusions:
- Parallel sequencing using NGS is a powerful, high-throughput, and cost-effective platform for mitochondrial genome sequencing.
- This approach provides the necessary sensitivity and specificity for reliable mtDNA heteroplasmy detection.
- NGS addresses the need for a single methodology capable of comprehensive mtDNA analysis, aiding in the molecular diagnosis of mitochondrial diseases.
Related Concept Videos
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
02:59Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
01:57Sanger Sequencing
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
03:21RNA-seq
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
01:05Maxam-Gilbert Sequencing
In the same year as the discovery of the Sanger sequencing method, another group of scientists, Allan Maxam and Walter Gilbert, demonstrated their chemical-cleavage method for DNA sequencing. The Maxam-Gilbert method relies on using different chemicals that can cleave the DNA sequence at specific sites, the separation of resulting DNA fragments of variable size using electrophoresis, and deciphering the DNA sequence from the resulting gel bands.
Challenges of the Maxam-Gilbert Method
The...
Challenges of the Maxam-Gilbert Method
The...
02:16Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...